INHIBRX, INC.

Profile

Company Names

INHIBRX, INC.

Addresses

11025 N. TORREY PINES ROAD, SUITE 200, LA JOLLA, CA 92037

11099 N. TORREY PINES ROAD, SUITE 280, LA JOLLA, CA 92037

Phone Numbers

(858) 795-1499
(858) 759-1499

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$668,550,639.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2023-08-31 
$200,000,633.00 
$200,000,633.00 
$0.00 
Equity 
4
2020-04-06 
$15,000,000.00 
$30,000,000.00 
$15,000,000.00 
Equity, Debt 
3
2019-05-20 
$40,000,000.00 
$40,000,000.00 
$0.00 
Equity, Debt 
2
2018-05-04 
$3,550,000.00 
$75,000,000.00 
$71,450,000.00 
Equity 
1
2018-04-30 
$410,000,006.00 
$410,000,006.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KELLY 
 
DECK 
EXECUTIVE OFFICER
INHIBRX, INC.
BRENDAN 
 
ECKELMAN 
DIRECTOR, EXECUTIVE OFFICER
INHIBRX, INC.
MARGERY 
 
FISCHBEIN 
DIRECTOR
CYTODEL, INC.   |  INHIBRX, INC.   |  PALISADE BIO, INC.
DOUG 
 
FORSYTH 
DIRECTOR
TICKETSAUCE.COM, INC.   |  INHIBRX, INC.
DOUGLAS 
 
FORSYTH 
DIRECTOR
ALLIANZ SHORT DURATION HIGH YIELD FUND   |  INHIBRX, INC.
JON 
 
KAYYEM 
DIRECTOR
OSMETECH PLC   |  INHIBRX, INC.
JON 
FAIZ 
KAYYEM 
DIRECTOR
OSMETECH PLC   |  INHIBRX, INC.
MARK 
 
LAPPE 
EXECUTIVE OFFICER, DIRECTOR
REPROS THERAPEUTICS INC.   |  INHIBRX, INC.
JUDITH 
 
LI 
DIRECTOR
NEXTCURE, INC.   |  VERITAS GENETICS INTERNATIONAL LTD.   |  E-SCAPE BIO, INC.   |  TMUNITY THERAPEUTICS, INC.   |  INHIBRX, INC.   |  RGENTA THERAPEUTICS, INC.   |  GRITSTONE BIO, INC.   |  ADARX PHARMACEUTICALS, INC.   |  AVENZO THERAPEUTICS, INC.
KIMBERLY 
 
MANHARD 
DIRECTOR
SHORELINE BIOSCIENCES, INC.   |  INHIBRX, INC.
KRISTIINA 
 
VUORI 
DIRECTOR
FORIAN INC.   |  INHIBRX, INC.   |  BIONANO GENOMICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-08-31
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2023-08-31 
2020-04-16
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity, Debt 
2020-04-06 
2019-05-31
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity, Debt 
2019-05-20 
2018-05-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-04 
2018-05-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#